Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 14, 2026
Why Is International Business Machines (IBM) Stock Down -22% Today?

Why Is International Business Machines (IBM) Stock Down -22% Today?

Key Takeaways

  • IBM shares are down approximately -22.00% in premarket trading, one of the steepest single-session declines in the company's modern history.
  • The primary catalyst is a preliminary second-quarter earnings disclosure that came in well below Wall Street's expectations, particularly in software and consulting revenue.
  • CEO Arvind Krishna addressed the shortfall directly in a letter to investors, citing softness across key business lines.
  • The move sharply diverges from the broader market and from IBM's own recent trading range, which had been consolidating near $290-$298.
  • Elevated premarket volume suggests institutional repositioning ahead of the official Q2 earnings release later this month.
  • Traders are now watching for the full Q2 report, updated full-year guidance, and analyst commentary to gauge whether the selloff is overdone or justified.

Opening Summary

International Business Machines Corporation, trading under the ticker IBM, is a legacy technology giant that has repositioned itself around hybrid cloud, enterprise software, consulting, and AI-enabled mainframe systems such as its Z-series. Shares of IBM fell roughly -22.00% in premarket trading Tuesday, sliding from Monday's close of $290.23 to around $226. The decline follows the company's release of preliminary second-quarter figures that missed Wall Street's expectations, prompting a swift and severe market reaction ahead of the official earnings call.

Preliminary Earnings Miss Drives the Selloff

The core catalyst behind today's move is IBM's preliminary second-quarter results, which came in below consensus estimates and triggered a "gut punch" reaction among investors. Reports indicate the shortfall was concentrated in the company's software and consulting segments, areas Wall Street has watched closely as bellwethers for IBM's broader AI-transformation strategy. CEO Arvind Krishna addressed the miss in a letter to investors, acknowledging weakness in these units, a rare and direct admission that has amplified concerns about the durability of IBM's growth narrative.

Mainframe Transition Concerns Resurface

Coverage of the selloff points to renewed pressure from IBM's ongoing mainframe business shift, with the preliminary numbers reigniting worries first seen in earlier 2026 selloffs tied to AI-driven disruption of legacy systems. Investors have grown increasingly sensitive to any signs that enterprise clients are delaying commitments to IBM's traditional infrastructure and software stack in favor of newer AI-native alternatives. This dynamic echoes concerns raised earlier this year when competitive AI announcements pressured IBM shares, though today's drop is materially larger in scale.

Market Context and Trading Activity

Premarket volume in IBM shares has been notably elevated relative to typical premarket activity, consistent with a broad, rapid repricing event rather than routine trading. The move stands in stark contrast to IBM's recent price action, where shares had traded in a relatively tight $287-$298 band over the prior week with no signs of stress. Because this decline is company-specific and tied to IBM's own preliminary disclosure, it does not appear to reflect a broader sector or index-wide move, marking a clear divergence from peers and the wider market. The scale of the drop also pushes shares through several recent technical support levels that had held during past pullbacks this year.

Trending AI Robots

For traders looking to navigate volatile sessions like today's IBM move, Tickeron's Trending AI Robots page offers a curated view of automated trading strategies performing well under current market conditions. Tickeron operates hundreds of AI-driven trading bots covering thousands of tickers, but only the top-performing bots, based on live performance metrics, are surfaced in this trending section. These bots vary widely by strategy type, trading timeframe, and the specific symbols they track, giving traders a snapshot of where algorithmic strategies are currently finding an edge. Investors interested in systematic approaches to days like this one may find it useful to explore the Trending AI Robots page for a closer look at current bot performance and methodology.

What Comes Next for IBM

Attention now shifts to IBM's official second-quarter earnings report and accompanying guidance update, where management is expected to elaborate on the drivers behind the preliminary miss, particularly within software and consulting. Analysts will be watching closely for any revision to full-year revenue growth and free cash flow targets, given the company's prior commitment to more than 5% constant-currency growth. Broader questions about how quickly AI-driven tools are reshaping demand for legacy enterprise services remain a key risk factor for the stock. Investors should also monitor analyst rating and price-target revisions in the coming sessions, as reactions to today's move begin to filter through Wall Street research.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: IBM

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


IBM in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 14, 2026

IBM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where IBM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IBM's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 28, 2026. You may want to consider a long position or call options on IBM as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IBM just turned positive on July 31, 2026. Looking at past instances where IBM's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in of 374 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

IBM moved below its 50-day moving average on July 14, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IBM crossed bearishly below the 50-day moving average on July 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.485) is normal, around the industry mean (7.293). P/E Ratio (21.060) is within average values for comparable stocks, (71.740). IBM's Projected Growth (PEG Ratio) (2.413) is slightly higher than the industry average of (1.207). Dividend Yield (0.028) settles around the average of (0.025) among similar stocks. P/S Ratio (3.266) is also within normal values, averaging (148.828).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IBM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 9.31B. The market cap for tickers in the group ranges from 0 to 223.42B. IBM holds the highest valuation in this group at 223.42B. The lowest valued company is ARSC at 0.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 0%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 64%. SHAZ experienced the highest price growth at 38%, while TTEC experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was -10%. For the same stocks of the Industry, the average monthly volume growth was -9% and the average quarterly volume growth was -42%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 64
Price Growth Rating: 57
SMR Rating: 72
Profit Risk Rating: 92
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
IBM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of various computer products through the use of advanced information technology

Industry InformationTechnologyServices

Profile
Details
Industry
Information Technology Services
Address
One New Orchard Road
Phone
+1 914 499-1900
Employees
305300
Web
http://www.ibm.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.